Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanying Sun

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Acta Pharmaceutica Sinica. B|July 19, 2024
Design and optimization of piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profilesYanying Sun, Zhenzhen Zhou, Zhongling Shi, et al.
ACS Infectious Diseases|July 4, 2020
Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIsDongwei Kang, Yanying Sun, N Arul Murugan, et al.
European Journal of Medicinal Chemistry|August 21, 2024
Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimizationLanlan Jing, Gaochan Wu, Fabao Zhao, et al.
Journal of Medicinal Chemistry|January 21, 2022
Development of Novel Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181CDongwei Kang, Yanying Sun, Da Feng, et al.
Journal of Medicinal Chemistry|April 13, 2024
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIsYanying Sun, Zhenzhen Zhou, Na Wang, et al.
Acta Pharmaceutica Sinica. B|June 13, 2020
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine derivatives as potent HIV-1 NNRTIsDongwei Kang, Da Feng, Tiziana Ginex, et al.
European Journal of Medicinal Chemistry|November 29, 2022
Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluationDa Feng, Hao Lin, Liyang Jiang, et al.
Journal of Medicinal Chemistry|November 21, 2022
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIsYanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry|March 18, 2021
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic StudiesDongwei Kang, Francesc X Ruiz, Yanying Sun, et al.
Journal of Medicinal Chemistry|January 15, 2020
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion ChannelDongwei Kang, F Xavier Ruiz, Da Feng, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Acta Pharmaceutica Sinica. B|July 19, 2024
Design and optimization of piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine-based HIV-1 NNRTIs with improved drug resistance and pharmacokinetic profilesYanying Sun, Zhenzhen Zhou, Zhongling Shi, et al.
ACS Infectious Diseases|July 4, 2020
Structure-Activity Relationship Exploration of NNIBP Tolerant Region I Leads to Potent HIV-1 NNRTIsDongwei Kang, Yanying Sun, N Arul Murugan, et al.
European Journal of Medicinal Chemistry|August 21, 2024
Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimizationLanlan Jing, Gaochan Wu, Fabao Zhao, et al.
Journal of Medicinal Chemistry|January 21, 2022
Development of Novel Dihydrofuro[3,4-<i>d</i>]pyrimidine Derivatives as HIV-1 NNRTIs to Overcome the Highly Resistant Mutant Strains F227L/V106A and K103N/Y181CDongwei Kang, Yanying Sun, Da Feng, et al.
Journal of Medicinal Chemistry|April 13, 2024
Discovery of Novel Aryl Triazolone Dihydropyridines (ATDPs) Targeting Highly Conserved Residue W229 as Promising HIV-1 NNRTIsYanying Sun, Zhenzhen Zhou, Na Wang, et al.
Acta Pharmaceutica Sinica. B|June 13, 2020
Exploring the hydrophobic channel of NNIBP leads to the discovery of novel piperidine-substituted thiophene[3,2-<i>d</i>]pyrimidine derivatives as potent HIV-1 NNRTIsDongwei Kang, Da Feng, Tiziana Ginex, et al.
European Journal of Medicinal Chemistry|November 29, 2022
Disubstituted pyrimidine-5-carboxamide derivatives as novel HIV-1 NNRTIs: Crystallographic overlay-based molecular design, synthesis, and biological evaluationDa Feng, Hao Lin, Liyang Jiang, et al.
Journal of Medicinal Chemistry|November 21, 2022
Lead Optimization and Avoidance of Metabolic-perturbing Motif Developing Novel Diarylpyrimidines as Potent HIV-1 NNRTIsYanying Sun, Zhenzhen Zhou, Da Feng, et al.
Journal of Medicinal Chemistry|March 18, 2021
2,4,5-Trisubstituted Pyrimidines as Potent HIV-1 NNRTIs: Rational Design, Synthesis, Activity Evaluation, and Crystallographic StudiesDongwei Kang, Francesc X Ruiz, Yanying Sun, et al.
Journal of Medicinal Chemistry|January 15, 2020
Discovery and Characterization of Fluorine-Substituted Diarylpyrimidine Derivatives as Novel HIV-1 NNRTIs with Highly Improved Resistance Profiles and Low Activity for the hERG Ion ChannelDongwei Kang, F Xavier Ruiz, Da Feng, et al.
Pageof 4